Login to Your Account



Transatlantic VC Fund Takes Aim at Rare Disease Space

By Nuala Moran
Staff Writer

Monday, June 24, 2013
LONDON – European and U.S. investors are joining forces to launch the first venture capital fund dedicated solely to investing in treatments for rare diseases.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription